Lidocaine enhances apoptosis and suppresses mitochondrial functions of human neutrophil in vitro

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 2, 2010, Pages 401-408

  Kawasaki, Chika ^a   Kawasaki, Takashi ^a,b   Ogata, Masanori ^a   Sata, Takeyoshi ^a   Chaudry, Irshad H ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b University of Alabama at Birmingham   (United States)

Author keywords

Apoptosis; Lidocaine; Local anesthetic; Mitochondria; Neutrophil

Indexed keywords

ADENOSINE TRIPHOSPHATE; BUPIVACAINE; LIDOCAINE; OLIGOMYCIN; ROPIVACAINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

AMIDES; ANESTHETICS, LOCAL; APOPTOSIS; BUPIVACAINE; CELLS, CULTURED; HUMANS; LIDOCAINE; MITOCHONDRIA; NEUTROPHILS; PHAGOCYTOSIS;

EID: 77249099383     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181af6e56     Document Type: Article

References (40)

1. Grimmond TR, Brownridge P. Antimicrobial activity of bupivacaine and pethidine. Anaesth Intensive Care. 1986;14:418-420.
2. Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 2000;93:858-875.
3. Rosenberg PH, Renkonen OV. Antimicrobial activity of bupivacaine and morphine. Anesthesiology. 1985;62:178-179.
4. Hyvonen PM, Kowolik MJ. Dose-dependent suppression of the neutrophil respiratory burst by lidocaine. Acta Anaesthesiol Scand. 1998;42: 565-569.
5. Kawasaki T, Kawasaki C, Ogata M, Shigematsu A. The effect of local anesthetics on monocyte mCD14 and human leukocyte antigen-DR expression. Anesth Analg. 2004;98:1024-1029.
6. Davis CF, Moore FD Jr, Rodrick ML, Fearon DT, Mannick JA. Neutrophil activation after burn injury: contributions of the classic complement pathway and endotoxin. Surgery. 1987;102:477-484.
7. Fukushima R, Alexander JW, Gianotti L, Pyles T, Ogle CK. Bacterial translocation-related mortality may be associated with neutriophilmediated organ damage. Shock. 1995;3:323-328.
8. Angle N, Hoyt DB, Coimbra R, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock. 1998;9:164-170.
9. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol. 1999;277(3, Part 2):R922-R929.
10. Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 2003;112:481-490.
11. Hu Z, Sayeed MM. Suppression of mitochondria-dependent neutrophil apoptosis with thermal injury. Am J Physiol Cell Physiol. 2004;286: C170-C178.
12. 2+ mediated neutrophil O responses with thermal injury. Am J Physiol Cell Physiol. 2002;283:C1469-C1479.
13. Fazal N, Shamim M, Khan SS, Gamelli RL, Sayeed MM. Neutrophil depletion in rats reduces burn-injury induced intestinal bacterial translocation. Crit Care Med. 2000;28:1550-1555.
14. Maianski NA, Mul FP, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood. 2002;99:672-679.
15. Adachi S, Kubota M, Wakazono Y, et al. Mechanism of enhancement of neutrophil survival by granulocyte colony-stimulating factor and adenine. Exp Hematol. 1993;21:1213-1218. (Pubitemid 24267132)
16. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB, et al. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood. 1998;92:4808-4818.
17. Derouet M, Thomas L, Moulding DA, et al. Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol. 2006;176:957-965.
18. Maianski NA, Maianski AN, Kuijpers TW, Roos D. Apoptosis of Neutrophils. Acta Haematol. 2004;111:56-66.
19. Doyle BT, O'Neill AJ, Newsholme P, Fitzpatrick JM, Watson RW. The loss of IAP expression during HL-60 cell differentiation is caspaseindependent. J Leukoc Biol. 2002;71:247-254.
20. Wajant H. The Fas signaling pathway: more than a paradigm. Science. 2002;296:1635-1636.
21. Arai Y, Kondo T, Tanabe K, et al. Enhancement of hyperthermiainduced apoptosis by local anesthetics on human histiocytic lymphoma U937 cells. J Biol Chem. 2002;277:18986-18993.
22. Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 1997;57:1835-1840. (Pubitemid 27209706)
23. Eguchi Y, Srinivasan A, Tomaselli KJ, Shimizu S, Tsujimoto Y. ATPdependent steps in apoptotic signal transduction. Cancer Res. 1999;59: 2174-2181.
24. Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 1995;26:406-417.
25. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 1997;411: 77-82.
26. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol. 2001;3:E255-E263.
27. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776.
28. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6:513-519.
29. Kamiya Y, Ohta K, Kaneko Y. Lidocaine-induced apoptosis and necrosis in U937 cells depending on its dosage. Biomed Res. 2005;26:231-239.
30. Fossati G, Moulding DA, Spiller DG, Moots RJ, White MR, Edwards SW. The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol. 2003;170:1964-1972.
31. Burm AG, van Kleef JW, Gladines MP, Olthof G, Spierdijk J. Epidural anesthesia with lidocaine and bupivacaine: effects of epinephrine on the plasma concentration profiles. Anesth Analg. 1986; 65:1281-1284.
32. Karmakar MK, Ho AM, Law BK, Wong AS, Shafer SL, Gin T. Arterial and venous pharmacokinetics of ropivacaine with and without epineph- rine after thoracic paravertebral block. Anesthesiology. 2005;103:704-711.
33. Tsai PS, Buerkle H, Huang LT, Lee TC, Yang LC, Lee JH. Lidocaine concentration in plasma and cerebrospinal fluid after systemic bolus administration in humans. Anesth Analg. 1998;87:601-604.
34. Brofeldt BT, Cornwell P, Doherty D, Batra K, Gunther RA. Topical lidocaine in the treatment of partial-thickness burns. J Burn Care Rehabil. 1989;10:63-68.
35. Holst D, Mollmann M, Scheuch E, Meissner K, Wendt M. Intrathecal local anesthetic distribution with the new spinocath catheter. Reg Anesth Pain Med. 1998;23:463-468.
36. Ala-Kokka TI, Löppönen A, Alahuhta S. Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block. Acta Anaesthesiol Scand. 2000;44:623-626.
37. Vainionpaa VA, Haavisto ET, Huha TM, et al. A clinical and pharmacokinetic comparison of ropivacaine and bupivacaine in axillary plexus block. Anesth Analg. 1995;81:534-538.
38. Wieczorek K, Hollman MW, Graf BM, Martin E, Durieux ME. Local anesthetics inhibit lysophosphatidate signaling time and pH dependent. Anaesthesiologie und Intensivmedizin. 2000;41:385.
39. Fink BR. Acute and chronic toxicity of local anaesthetics. Can Anaesth Soc J. 1973;20:5-16.
40. Du Pen SL, Peterson DG, Williams A, Bogosian AJ. Infection during chronic epidural catheterization: diagnosis and treatment. Anesthesiology. 1990;73:905-909.